grant

HIV persistence in vivo

NIHUS FederalResearch GrantFY2025AIDS VirusAcquired Immune Deficiency Syndrome VirusAcquired Immunodeficiency Syndrome VirusAffectBlood SampleBlood specimenCD4 CellsCD4 Positive T LymphocytesCD4 T cellsCD4 helper T cellCD4 lymphocyteCD4+ T-LymphocyteCD4-Positive LymphocytesCell BodyCell FunctionCell Growth in NumberCell MultiplicationCell PhysiologyCell ProcessCell ProliferationCellsCellular FunctionCellular PhysiologyCellular ProcessCellular ProliferationChronicDetectionDevelopmentEmulsionsEpigeneticEpigenetic ChangeEpigenetic MechanismEpigenetic ProcessExpression SignatureFlow CytofluorometriesFlow CytofluorometryFlow CytometryFlow MicrofluorimetryFlow MicrofluorometryGene Expression ProfileGenomic DNAGoalsHIVHIV InfectionsHTLV-III InfectionsHTLV-III-LAV InfectionsHuman Immunodeficiency VirusesHuman T-Lymphotropic Virus Type III InfectionsHydrogen OxideImmunochemical ImmunologicImmunologicImmunologicalImmunologicallyImmunologicsIndividualInstitutionInterruptionLAV-HTLV-IIILymphadenopathy-Associated VirusMorbidityMorbidity - disease rateOilsParticipantPhenotypePopulationSortingSubcellular ProcessT-Cell SubsetsT-Lymphocyte SubsetsT4 CellsT4 LymphocytesTissue SampleVirusVirus ReplicationVirus-HIVWaterWorkantiretroviral therapyantiretroviral treatmentcell typedevelopmentalepigeneticallyflow cytophotometrygDNAgene expression patterngene expression signaturein vivointervention designmortalitynovelpreventpreventingproteomic signaturetherapy designtranscriptional profiletranscriptional signaturetranscriptomicstreatment designviral multiplicationviral replicationvirus multiplication
Sign up free to applyApply link · pipeline · email alerts
— or —

Get email alerts for similar roles

Weekly digest · no password needed · unsubscribe any time

Description preview

The purpose of this project is to help elucidate how HIV persists in vivo and thus to aid the development of novel HIV cure-directed therapies. The focus of the work is a small population of CD4 T cells that contain replication-competent HIV and persist at nearly stable levels even in the setting of effective antiretroviral therapy (ART).…

🔒

Full details available on the Agency plan

Unlock the complete grant description, eligibility criteria, contract value, evaluation details and apply link — plus alerts, pipeline tracking, and CSV export.

Start 7-day free trial — $29.99/mo →

Agency Plan

7-day free trial

Unlock procurement & grants

Upgrade to access active tenders from World Bank, UNDP, ADB and more — with email alerts and pipeline tracking.

$29.99 / month

  • 🔔Email alerts for new matching tenders
  • 🗂️Track tenders in your pipeline
  • 💰Filter by contract value
  • 📥Export results to CSV
  • 📌Save searches with one click
Start 7-day free trial →
HIV persistence in vivo — NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES | UNITED STATES | Dev Procure